Compare MOLN & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MOLN | CMTL |
|---|---|---|
| Founded | 2004 | 1967 |
| Country | Switzerland | United States |
| Employees | N/A | 1385 |
| Industry | | Radio And Television Broadcasting And Communications Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.9M | 162.1M |
| IPO Year | 2021 | 2024 |
| Metric | MOLN | CMTL |
|---|---|---|
| Price | $5.02 | $5.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.38 | $6.00 |
| AVG Volume (30 Days) | 4.3K | ★ 258.5K |
| Earning Date | 01-01-0001 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $499,528,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $285.71 | $1.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.36 | $1.19 |
| 52 Week High | $5.10 | $6.21 |
| Indicator | MOLN | CMTL |
|---|---|---|
| Relative Strength Index (RSI) | 67.88 | 47.04 |
| Support Level | $3.50 | $5.34 |
| Resistance Level | N/A | $6.15 |
| Average True Range (ATR) | 0.17 | 0.37 |
| MACD | 0.05 | -0.08 |
| Stochastic Oscillator | 97.80 | 40.00 |
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.